197 related articles for article (PubMed ID: 33105566)
1. Investigation of the Impact from IL-2, IL-7, and IL-15 on the Growth and Signaling of Activated CD4
Coppola C; Hopkins B; Huhn S; Du Z; Huang Z; Kelly WJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105566
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
4. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.
Bullenkamp J; Mengoni V; Kaur S; Chhetri I; Dimou P; Astroulakis ZMJ; Kaski JC; Dumitriu IE
Cardiovasc Res; 2021 Jul; 117(8):1935-1948. PubMed ID: 32647892
[TBL] [Abstract][Full Text] [Related]
6. An In-Vitro Study of the Expansion and Transcriptomics of CD
Hopkins B; Fisher J; Chang M; Tang X; Du Z; Kelly WJ; Huang Z
Cells; 2022 May; 11(10):. PubMed ID: 35626739
[TBL] [Abstract][Full Text] [Related]
7. Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis.
Neitzke DJ; Bowers JS; Andrijauskaite K; O'Connell NS; Garrett-Mayer E; Wrangle J; Li Z; Paulos CM; Cole DJ; Rubinstein MP
Cancer Immunol Immunother; 2017 Jun; 66(6):737-751. PubMed ID: 28280853
[TBL] [Abstract][Full Text] [Related]
8. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.
Kooy-Winkelaar YM; Bouwer D; Janssen GM; Thompson A; Brugman MH; Schmitz F; de Ru AH; van Gils T; Bouma G; van Rood JJ; van Veelen PA; Mearin ML; Mulder CJ; Koning F; van Bergen J
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E980-E989. PubMed ID: 28049849
[TBL] [Abstract][Full Text] [Related]
9. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
[TBL] [Abstract][Full Text] [Related]
10. IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells.
Caserta S; Alessi P; Basso V; Mondino A
Eur J Immunol; 2010 Feb; 40(2):470-9. PubMed ID: 19950184
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.
Nguyen TP; Bazdar DA; Mudd JC; Lederman MM; Harding CV; Hardy GA; Sieg SF
J Leukoc Biol; 2015 Jun; 97(6):1139-46. PubMed ID: 25784743
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced survival of activated T cells in vitro and in vivo.
Vella AT; Dow S; Potter TA; Kappler J; Marrack P
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3810-5. PubMed ID: 9520449
[TBL] [Abstract][Full Text] [Related]
13. [Influence of immunoregulatory cytokines (IL-2, IL-7 and IL-15) in vitro upon activation, proliferation and apoptosis of immune memory T-cells].
Litvinova LS; Sokhonevich NA; Gutsol AA; Kofanova KA
Tsitologiia; 2013; 55(8):566-71. PubMed ID: 25486789
[TBL] [Abstract][Full Text] [Related]
14. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
[TBL] [Abstract][Full Text] [Related]
15. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
Grundström S; Dohlsten M; Sundstedt A
J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
[TBL] [Abstract][Full Text] [Related]
16. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
Wang ZH; Zhu JY; Li T; Leng XS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
[TBL] [Abstract][Full Text] [Related]
17. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
18. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
[TBL] [Abstract][Full Text] [Related]
19. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
Niedbala W; Wei X; Liew FY
Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]